Brian G. Atwood is an entrepreneur and businessperson who founded 6 companies, among them: Glycomed, Inc., Versant Venture Management LLC and Versant Ventures I LLC and who has been at the helm of 7 different companies. Presently, Mr. Atwood occupies the position of Chairman at Atreca, Inc. and Chairman for Phoenix Biotech Acquisition Corp. Mr. Atwood is also on the board of Biotechnology Innovation Organization, PhaseRx, Inc. and Clovis Oncology, Inc.

In his past career he was Chairman for Veracyte, Inc., General Partner for Brentwood Associates and General Partner of Brentwood Venture Capital (a subsidiary of Brentwood Associates), Board Member at Accelerator Services Corp., Managing Director at Versant Venture Management LLC (he founded the company in 1999) Managing Director at Versant Ventures I LLC, Managing Director at Versant Venture Capital III LP, Managing Director at Versant Ventures II LLC, Managing Director at Versant Ventures III LLC and Managing Director at Versant Ventures IV LLC (which are all subsidiaries of Versant Venture Management LLC), Chairman for Five Prime Therapeutics, Inc., Chairman at Locust Walk Acquisition Corp., President & Chief Executive Officer at Glycomed, Inc. (he founded the company in 1987), Director at Cell Design Labs, Inc. (he founded the company in 2015), Director at PE Corp. (New York) and Director at Perkin-Elmer Cetus Instruments.

Mr. Atwood received a graduate degree from the University of California, Davis, an undergraduate degree from the University of California, Irvine and an MBA from Harvard Business School.